BIOLASE logoBIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. It offers two categories of laser system products: WaterLase (all-tissue) systems and Diode (soft tissue) systems. Its brand, WaterLase, uses a combination of water and laser energy to perform procedures performed using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. It also offers its Diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:BLTI
  • CUSIP: N/A
  • Web:
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
  • Dividend Yield: 1.0%
  • Net Margins: -34.01%
  • Return on Equity: -151.86%
  • Return on Assets: -43.37%

Frequently Asked Questions for BIOLASE (NASDAQ:BLTI)

What is BIOLASE's stock symbol?

BIOLASE trades on the NASDAQ under the ticker symbol "BLTI."

Who are some of BIOLASE's key competitors?

Who are BIOLASE's key executives?

BIOLASE's management team includes the folowing people:

  • Paul N. Clark, Independent Chairman of the Board
  • Harold C. Flynn Jr., President, Chief Executive Officer
  • Brendan O'Connell, Vice President - Finance and Corporate Controller
  • Holger Arens, Vice President, Managing Director of Europe, the Middle East and Africa
  • James D. Surek, Vice President - Sales, Americas
  • Michael Roux, Vice President of Marketing
  • Matthew Wilson, Vice President of Human Resources
  • Samuel B. Low, Vice President - Dental and Clinical Affairs, Chief Dental Officer
  • George W. Bickerstaff III, Director
  • Tamar D. Howson, Director

Who owns BIOLASE stock?

BIOLASE's stock is owned by a number of of retail and institutional investors. Top institutional investors include SCHULER JACK W (28.71%). View Institutional Ownership Trends for BIOLASE.

How do I buy BIOLASE stock?

Shares of BIOLASE can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BIOLASE's stock price today?

One share of BIOLASE stock can currently be purchased for approximately $2.42.

MarketBeat Community Rating for BIOLASE (NASDAQ BLTI)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  74
MarketBeat's community ratings are surveys of what our community members think about BIOLASE and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for BIOLASE (NASDAQ:BLTI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for BIOLASE (NASDAQ:BLTI)
No equities research coverage for this company has been tracked by


Earnings History for BIOLASE (NASDAQ:BLTI)
No earnings announcements for this company have been tracked by


Earnings Estimates for BIOLASE (NASDAQ:BLTI)
Current Year EPS Consensus Estimate: $-0.43 EPS


Dividend History for BIOLASE (NASDAQ:BLTI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for BIOLASE (NASDAQ:BLTI)
No insider trades for this company have been tracked by


Headline Trends for BIOLASE (NASDAQ:BLTI)
Latest Headlines for BIOLASE (NASDAQ:BLTI)
DateHeadline logoCritical Contrast: LeMaitre Vascular (LMAT) & BIOLASE (BLTI) - July 19 at 8:40 PM logoReviewing BIOLASE (BLTI) and Koninklijke Philips N.V. (PHG) - June 30 at 9:09 AM



BIOLASE (BLTI) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by Staff